MARKET

AGTC

AGTC

Applied Genetic
NASDAQ
0.2743
+0.0092
+3.47%
Pre Market: 0.3000 +0.0257 +9.37% 06:29 10/05 EDT
OPEN
0.2660
PREV CLOSE
0.2651
HIGH
0.2825
LOW
0.2651
VOLUME
8.82K
TURNOVER
--
52 WEEK HIGH
3.180
52 WEEK LOW
0.2571
MARKET CAP
18.55M
P/E (TTM)
-0.1786
1D
5D
1M
3M
1Y
5Y
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket
Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada.
Benzinga · 1h ago
Expert Ratings for Applied Genetic
Applied Genetic (NASDAQ:AGTC) has observed the following analyst ratings within the last quarter:
Benzinga · 15h ago
This Analyst Sees $196 For Meta? Plus Wells Fargo Slashes PT On This Stock By 96%
B of A Securities cut the price target on Meta Platforms, Inc. (NASDAQ: META) from $218 to $196. B of A Securities analyst Justin Post maintained a Buy rating on the stock. Meta shares rose 1.9% to $141.20 in pre-market trading.
Benzinga · 23h ago
Wells Fargo Downgrades Applied Genetic to Equal-Weight, Lowers Price Target to $0.5
Wells Fargo analyst Yanan Zhu downgrades Applied Genetic (NASDAQ:AGTC) from Overweight to Equal-Weight and lowers the price target from $12 to $0.5.
Benzinga · 1d ago
--Wells Fargo Downgrades Applied Genetic Technologies to Equalweight From Overweight, Adjusts Price Target to $0.50 From $12
--Wells Fargo Downgrades Applied Genetic Technologies to Equalweight From Overweight, Adjusts Price Target to $0.50 From $12
MT Newswires · 1d ago
HC Wainwright & Co. Maintains Buy Rating for Applied Genetic: Here's What You Need To Know
HC Wainwright & Co. has decided to maintain its Buy rating of Applied Genetic (NASDAQ:AGTC) and lower its price target from $24.00 to $16.00. Shares of Applied Genetic are trading up 6.21% over the last 24 hours, at $0.29 per share.
Benzinga · 4d ago
Stifel Maintains Buy on Applied Genetic, Lowers Price Target to $3
Stifel analyst Dae Gon Ha maintains Applied Genetic (NASDAQ:AGTC) with a Buy and lowers the price target from $10 to $3.
Benzinga · 5d ago
HC Wainwright & Co. Maintains Buy on Applied Genetic, Lowers Price Target to $16
HC Wainwright & Co. analyst Joseph Pantginis maintains Applied Genetic (NASDAQ:AGTC) with a Buy and lowers the price target from $24 to $16.
Benzinga · 5d ago
More
About AGTC
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic therapies for patients suffering from rare and debilitating diseases. Its focus is on the field of ophthalmology where it has active clinical programs in X-linked retinitis pigmentosa (XLRP), achromatopsia (ACHM) and a optogenetics program, as well as a preclinical program in dry age-related macular degeneration (dAMD). It has approximately one preclinical program in otology and two preclinical programs targeting central nervous system disorders (CN), including frontotemporal dementia and amyotrophic lateral sclerosis. Its optogenetics program is being developed in collaboration with Bionic Sight, LLC and its otology program is being developed in collaboration with Otonomy, Inc. In addition to its product pipeline, the Company has also developed broad technological and manufacturing capabilities in synthetic promoter development and optimization.

Webull offers kinds of Applied Genetic Technologies Corp stock information, including NASDAQ:AGTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGTC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGTC stock methods without spending real money on the virtual paper trading platform.